Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Reason Magazine (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Autism Research Doesn't Need Washington's Help

% of readers think this story is Fact. Add your two cents.


Donald Trump and Robert F. Kennedy Jr. | CNP/AdMedia/SIPA/Newscom

At a well-attended press event in September, Health and Human Services Secretary Robert F. Kennedy Jr. announced a “bold” new initiative to identify the causes and treatments for autism. Citing research suggesting a possible link between taking acetaminophen during pregnancy and neurodevelopmental disorders, including autistic spectrum disorder (ASD), the initiative included the National Institutes of Health spending $50 million more on research into acetaminophen and other possible environmental causes of what Kennedy called an “epidemic” of autism.

Set aside the fact that the so-called epidemic of autism does not result from a surge in actual cases but from a broadening of the diagnosis over the past 50 years—from what psychiatrists in the 1970s called a form of childhood schizophrenia, marked by early social withdrawal, impaired language, and rigid, repetitive behaviors, to today’s ASD. This new understanding includes highly capable, sometimes gifted individuals who simply interact with others in unusual or atypical ways. Additionally, because social, educational, and health care services are now more accessible to children with ASD, increased parental awareness and more screening by pediatricians, school psychologists, and educators have led to greater detection. 

That nuance seems lost on Kennedy, who treats autism as if it were an infection or a tumor. But government bureaucrats don’t usually do nuance very well.

The scientific research Kennedy cited to support his suspicion of acetaminophen’s role was all conducted by clinical researchers, unconnected to this administration or political agendas. This behavior isn’t unique to Kennedy. Politicians of every stripe can’t resist the urge to hitch themselves to science, claiming breakthroughs that are already underway or steering research toward pet causes.

For example, President Donald Trump signed an executive order to “unlock cures for pediatric cancer” by allocating $100 million in federal funds to improve the use of artificial intelligence (AI) in cancer research. But, AI is already transforming medical research by analyzing genomics, imaging, and clinical records to improve diagnostics, accelerate drug discovery, and tailor treatments for patients. This progress results from technological advancement and necessity, not government intervention. The government can, at best, influence the pace; at worst, it distorts progress for political show. Trump’s executive order wasn’t about leadership—it was about wanting to be seen at the front of the parade. 

When the government involves itself in the scientific debate—usually through funding initiatives—it distorts researchers’ agendas and direction. 

Medical scientist Terence Kealey sees the food pyramid as a textbook case of government distorting science. When the 1977 Senate Select Committee on Nutrition and Human Needs adopted Ancel Keys’ unproven theory linking saturated fat to heart disease, it encouraged Americans to replace fats with carbs. That policy change contributed to the rise of trans fats and coincided with increasing rates of obesity and diabetes. Kealey argues that when the government involves itself in research, it doesn’t just fund science—it influences it, often in ways that mislead the public.

The food pyramid illustrates the disastrous consequences that can result when diet policy is hijacked by politicians. The same risk looms now with autism research: Will the White House’s suspicion of acetaminophen skew inquiry away from more valuable discoveries? The “fact sheet” that White House Press Secretary Karoline Leavitt issued, titled “Evidence Suggests a Link Between Acetaminophen, Autism,” would certainly lead readers to draw that conclusion.

The fact sheet cites five “studies” to support its claim. Two of them, a “Harvard study” and a “Mount Sinai study,” are actually the same study—one of the authors was part of Harvard’s faculty and the other was affiliated with the Mount Sinai School of Medicine. A third study examined acetaminophen levels in the meconium (stool) of newborns, which makes it hard to determine the timing and duration of exposure. The remaining two studies had similar limitations and involved cohorts that might not be representative of the population. 

The fact sheet also cited a “consensus statement” by clinicians urging their colleagues to be cautious and judicious when recommending acetaminophen to pregnant patients with fever, to which the American College of Obstetrics and Gynecology responded, “The authors are not recommending anything counter to what is already done by obstetrician-gynecologists when prescribing acetaminophen for a given clinical condition.” In other words, “Thanks, we’ve got this.”

Glaringly absent from Leavitt’s fact sheet was a crucial study from Sweden, published in 2024,  which followed nearly 2.5 million children born in Sweden between 1995 and 2019, using sibling controls. It found “no evidence that acetaminophen use during pregnancy was associated with autism…or intellectual disability.” Its conclusion stated that acetaminophen during pregnancy was “not associated with children’s risk of autism, ADHD, or intellectual disability.”

As the saying goes, “He who pays the piper calls the tune.” President Dwight D. Eisenhower cautioned that “public policy could itself become the captive of a scientific-technological elite.” That warning rings true today: Researchers who depend on federal grants know their chances for funding shrink if their work runs counter to the prevailing narrative.

Kealey argues that government funding of science is not only unnecessary but often counterproductive. He points to history, where science thrived under private patronage and market demand long before bureaucracies took over. Public funding, he says, crowds out private investment, replacing risk-taking with conformity and steering research toward politically advantageous or “safe” projects. Instead of speeding up discovery, government agencies slow it down by forcing scientists to chase grants rather than pursue ideas. According to Kealey, status, recognition, and peer competition naturally drive innovation, and when left alone, markets and private actors are more than capable of supporting it.

What we know so far about the link between prenatal acetaminophen and autism—that it remains inconclusive—is based on independent clinical studies not influenced by a government agenda. Without government interference, these studies might find definitive proof that prenatal acetaminophen causes ASD, or they could lead to dead ends, encouraging scientists to explore other possibilities. Scientific research is a process of trial and error.

In a free society, government has a limited but legitimate role in public health: protecting people when one person’s actions threaten the lives or safety of others. Too often, however, government directs research and policy toward personal health decisions that individuals can make for themselves, with expert advice if they choose. 

When a public health agency issues opinions on personal health, those opinions quickly gain the force of mandates—disclaimers notwithstanding. History shows how badly this can go, from the food pyramid fiasco to the heavy-handed COVID-19 response that silenced dissent. Good public health policy requires humility, precision, and honesty. If we want a healthier future for our children, we must reject ready-made conclusions and insist on evidence over ideology. When the state dictates both the questions science asks and the answers it offers, it converts knowledge into propaganda and health into a matter of politics.

We don’t need Washington to endorse a favored theory or influence the outcome; we need honest, independent science that can follow the evidence wherever it leads. The Swedish study that challenges the acetaminophen story shows researchers are capable of figuring this out without political interference. Parents deserve straight answers, not government-produced fiction. 

So thanks for the offer, Mr. Secretary—but when it comes to understanding autism, we’ve got this.

The post Autism Research Doesn’t Need Washington’s Help appeared first on Reason.com.


Source: https://reason.com/2025/10/02/autism-research-doesnt-need-washingtons-help/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login